SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : URMD -- Huge market potential
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Lawrence Burg who wrote (212)2/27/1998 11:41:00 AM
From: TheCat  Read Replies (1) of 369
 
I do not do TA but URMD is clearly over sold. An institution sold 2 million shares at $2 earlier this week. I wish I had the money because I would have liked to own that much stock at those prices.

At $2.5 URMD has good fundamentals. The market cap is only $65 million and they have that much cash on their balance sheet. The convertible preferred is in very good hands (Reliance Financial) and should not be a problem. The preferred is not convertible until the stock is up 500% from these levels.

Basically, the market is giving no value to URMD's FDA approved products. I am excited about Cavermap, Impress and Breast Check. The restructuring was very positive for the company. It will not keep burning money on doing something they are not good at. If a big partner, like JNJ, markets the over the counter version of Impress it will really take off. The adult diaper market is over $2billion. Once Impress starts to sell. URMD's entire line of incontinence products should start to sell. Milestones with regard to impress include FDA approval to market over the counter and a partnership agreement. [If I were a large pharmaceutical company I would just take over URMD].

Cavermap is very exciting. URMD has good relationships in the urology area and selling to doctors is a lot more suited to URMD than selling directly to the public. No patient undergoing prostate cancer surgery would let the procedure go without it.

At the end of 1998 we all will be kicking ourselves for not buying URMD at $2.5.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News